Divalproex-extended release monotherapy and adjunctive therapy in bipolar II depression

被引：0
|
作者：
Keffer, T. A. [1 ]
Wang, P. W. [1 ]
Nowakowska, C. [1 ]
Chandler, R. A. [1 ]
Hill, S. J. [1 ]
Nam, J. Y. [1 ]
Culver, J. L. [1 ]
Keller, K. L. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
BIPOLAR DISORDERS | 2007年 / 9卷
关键词：
divalproex; monotherapy; adjunctive therapy; bipolar II disorder; depression;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [41] Long-Term Safety of Divalproex Sodium Extended-Release in Children and Adolescents with Bipolar I Disorder
    Redden, Laura
    DelBello, Melissa
    Wagner, Karen Dineen
    Wilens, Timothy E.
    Malhotra, Shishuka
    Wozniak, Patricia
    Vigna, Namita V.
    Greco, Nicholas
    Kovacs, Xenia
    Abi-Saab, Walid
    Saltarelli, Mario
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (01) : 83 - 89
  • [42] Net benefit analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder
    Gupta, S. R.
    Schumock, G. T.
    Walton, S. M.
    Cramer, J. A.
    VALUE IN HEALTH, 2007, 10 (03) : A73 - A74
  • [43] Effectiveness of lithium versus quetiapine extended release monotherapy in patients with bipolar spectrum disorder
    Gao, K.
    Goto, T.
    Brownrigg, B.
    Conroy, C.
    Chan, P.
    Serrano, M. B.
    Ganocy, S.
    Calabrese, J.
    BIPOLAR DISORDERS, 2016, 18 : 98 - 98
  • [44] Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials
    Maruki, Taku
    Utsumi, Tomohiro
    Takeshima, Masahiro
    Fujiwara, Yu
    Matsui, Marie
    Aoki, Yumi
    Toda, Hiroyuki
    Watanabe, Norio
    Watanabe, Koichiro
    Takaesu, Yoshikazu
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2022, 10 (01)
  • [45] Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials
    Taku Maruki
    Tomohiro Utsumi
    Masahiro Takeshima
    Yu Fujiwara
    Marie Matsui
    Yumi Aoki
    Hiroyuki Toda
    Norio Watanabe
    Koichiro Watanabe
    Yoshikazu Takaesu
    International Journal of Bipolar Disorders, 10
  • [46] Efficacy of atypical antipsychotics in the treatment of bipolar depression: A systematic review and meta-analysis of placebo-controlled monotherapy and adjunctive therapy trials
    Hagi, K.
    Nosaka, T.
    Pikalov, A.
    Loebel, A.
    BIPOLAR DISORDERS, 2019, 21 : 128 - 129
  • [47] BOLDER II study of quetiapine therapy for bipolar depression
    Thase, Michael E.
    FUTURE NEUROLOGY, 2007, 2 (04) : 373 - 377
  • [48] Benefits and harms of atypical antipsychotics in the treatment of bipolar depression: A systematic review and meta-analysis of placebo-controlled monotherapy and adjunctive therapy trials
    Hagi, K.
    Nosaka, T.
    Pikalov, A.
    Loebel, A.
    BIPOLAR DISORDERS, 2019, 21 : 128 - 128
  • [49] BENEFITS AND HARMS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF BIPOLAR DEPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PLACEBO-CONTROLLED MONOTHERAPY AND ADJUNCTIVE THERAPY TRIALS
    Hagi, K.
    Nosaka, T.
    Pikalov, A.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 104 - 104
  • [50] Safety and tolerability of atypical antipsychotics in the treatment of bipolar depression: A systematic review and meta-analysis of placebo-controlled monotherapy and adjunctive therapy trials
    Hagi, K.
    Nosaka, T.
    Pikalov, A.
    Loebel, A.
    BIPOLAR DISORDERS, 2019, 21 : 129 - 130
12345